LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 18th Prioritisation – 1st quarter 2014

Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 18th Prioritisation – 1st quarter 2014. HSO: 18th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
363Kb
Abstract

For the 18th prioritisation (March 2014), 12 anticancer therapies were filtered out of 192 identified and were sent to prioritisation. Of these, 7 drugs were ranked as 'highly relevant' by the expert panel, 4 as 'relevant' and one as 'not relevant'. For 'highly relevant' drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
Language:English
Series Name:HSO: 18th Prioritisation
Deposited on:15 May 2014 15:58
Last Modified:27 Oct 2014 14:03

Repository Staff Only: item control page